# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000875045-17-000007
Filing Date
2017-02-02
Accepted
2017-02-02 07:46:12
Documents
4
Period of Report
2017-02-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | a8-kbioverativspinxoff.htm | 8-K | 24745
2 | EXHIBIT 2.1 | ex21_separationxagreement.htm | EX-2.1 | 539719
3 | EXHIBIT 99.1 | ex991pressrelease2-1x17.htm | EX-99.1 | 13247
4 |  | biogenlogostandarda09.jpg | GRAPHIC | 756402
| Complete submission text file | 0000875045-17-000007.txt |  | 1600259

Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 17566733
SIC: 2836 Biological Products, (No Diagnostic Substances)